• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道药物对人肝微粒体中CYP活性的抑制作用。

Inhibitory Effects of Gastrointestinal Drugs on CYP Activities in Human Liver Microsomes.

作者信息

Iwase Mariko, Nishimura Yuki, Kurata Norimitsu, Namba Hokuto, Hirai Takahito, Kiuchi Yuji

机构信息

Department of Pharmacology, Showa University School of Medicine.

Faculty of Arts and Sciences at Fujiyoshida, Showa University.

出版信息

Biol Pharm Bull. 2017;40(10):1654-1660. doi: 10.1248/bpb.b17-00118.

DOI:10.1248/bpb.b17-00118
PMID:28966237
Abstract

OTC drugs have an important role in self-medication. However, the pharmacokinetic properties of some OTC drugs have not been fully investigated and reports concerning their drug interactions are insufficient. Several gastrointestinal drugs are available as OTC drugs. Because of their pharmacological properties, these drugs are often used concomitantly with other drugs. Therefore, it is important to predict the possible drug interactions among these drugs. In the current study, we investigated the inhibitory effects of five gastrointestinal drugs, namely loperamide, oxethazaine, papaverine, pirenzepine, and trimebutine, on CYP activities in human liver microsomes. Furthermore, we calculated the ratio of the intrinsic clearance of each CYP substrate in the presence or absence of the gastrointestinal drugs. The possibility of drug interactions in vivo was predicted by cut-off criteria. CYP3A4 activity was markedly inhibited by trimebutine, papaverine, and oxethazaine. Their inhibitory properties were competitive and the K values were 6.56, 12.8, and 3.08 µM, respectively. Alternative R values of CYP3A4 exceeded the cut-off level. These results suggested that drug interactions mediated by CYP3A4 may occur during treatment with these gastrointestinal drugs, necessitating the confirmation of the clinical significance of these drug interactions to prevent unexpected adverse effects.

摘要

非处方药在自我药疗中发挥着重要作用。然而,一些非处方药的药代动力学特性尚未得到充分研究,有关其药物相互作用的报道也不足。有几种胃肠药物作为非处方药可供使用。由于其药理特性,这些药物常与其他药物联合使用。因此,预测这些药物之间可能的药物相互作用很重要。在本研究中,我们研究了五种胃肠药物,即洛哌丁胺、奥昔卡因、罂粟碱、哌仑西平和曲美布汀对人肝微粒体中细胞色素P450(CYP)活性的抑制作用。此外,我们计算了存在或不存在胃肠药物时每种CYP底物的内在清除率比值。通过截断标准预测体内药物相互作用的可能性。曲美布汀、罂粟碱和奥昔卡因显著抑制CYP3A4活性。它们的抑制特性是竞争性的,K值分别为6.56、12.8和3.08µM。CYP3A4的替代R值超过截断水平。这些结果表明,在用这些胃肠药物治疗期间可能发生由CYP3A4介导的药物相互作用,有必要确认这些药物相互作用的临床意义以预防意外的不良反应。

相似文献

1
Inhibitory Effects of Gastrointestinal Drugs on CYP Activities in Human Liver Microsomes.胃肠道药物对人肝微粒体中CYP活性的抑制作用。
Biol Pharm Bull. 2017;40(10):1654-1660. doi: 10.1248/bpb.b17-00118.
2
Inhibitory Potential of Twenty Five Anti-tuberculosis Drugs on CYP Activities in Human Liver Microsomes.二十五种抗结核药物对人肝微粒体中细胞色素P450酶活性的抑制潜力
Biol Pharm Bull. 2015;38(9):1425-9. doi: 10.1248/bpb.b15-00313. Epub 2015 Jun 20.
3
Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes.仙茅苷对人肝脏细胞色素P450酶的抑制作用。
Xenobiotica. 2017 Oct;47(10):849-855. doi: 10.1080/00498254.2016.1257171. Epub 2017 Jul 3.
4
Inhibitory effect of 5-fluorouracil on human cytochrome P(450) isoforms in human liver microsomes.5-氟尿嘧啶对人肝微粒体中细胞色素P450同工酶的抑制作用。
Eur J Clin Pharmacol. 2003 Sep;59(5-6):407-9. doi: 10.1007/s00228-003-0641-z. Epub 2003 Aug 5.
5
Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein.雷公藤甲素对人肝脏细胞色素P450酶和P-糖蛋白的抑制作用
Eur J Drug Metab Pharmacokinet. 2017 Feb;42(1):89-98. doi: 10.1007/s13318-016-0323-8.
6
In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin.大豆苷元对人细胞色素P450 1A2、2C9、3A4/5、2D6和2E1的体外抑制作用
Planta Med. 2017 May;83(8):727-736. doi: 10.1055/s-0042-124615. Epub 2017 Jan 10.
7
Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.美金刚对人细胞色素P450活性的抑制作用:体内药物相互作用的预测
Eur J Clin Pharmacol. 2004 Oct;60(8):583-9. doi: 10.1007/s00228-004-0825-1. Epub 2004 Sep 16.
8
Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.米卡霉素的细胞色素P450(CYP)介导的代谢特性研究:评估与CYP形成代谢中间复合物的可能性以及鉴定人CYP同工酶。
Drug Metab Dispos. 2000 Apr;28(4):409-17.
9
Inhibition of cytochrome P450 enzymes by saturated and unsaturated fatty acids in human liver microsomes, characterization of enzyme kinetics in the presence of bovine serum albumin (0.1 and 1.0% w/v) and in vitro - in vivo extrapolation of hepatic clearance.饱和脂肪酸和不饱和脂肪酸对人肝微粒体细胞色素P450酶的抑制作用、牛血清白蛋白(0.1%和1.0% w/v)存在下酶动力学的表征以及肝清除率的体外-体内外推
Eur J Pharm Sci. 2017 Apr 1;101:80-89. doi: 10.1016/j.ejps.2017.01.027. Epub 2017 Feb 4.
10
Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes.细胞色素P-4502C9在人肝微粒体对厄贝沙坦氧化中的作用。
Drug Metab Dispos. 1999 Feb;27(2):288-96.

引用本文的文献

1
Update of the Scientific Opinion on opium alkaloids in poppy seeds.罂粟籽中鸦片生物碱的科学意见更新。
EFSA J. 2018 May 16;16(5):e05243. doi: 10.2903/j.efsa.2018.5243. eCollection 2018 May.